NCT01970228

Brief Summary

Total hip replacement is the well-established surgical method for treatment of hip osteoarthritis and related diseases. The outcome of the procedure is commonly satisfactory and most patients will not need any revision surgery. However, the procedure has its complications, including (1) periprosthetic infection, (2) mechanical loosening caused by wear particles and (3) adverse reaction caused by metal ions released from metal-on-metal bearing surfaces. The unsolved clinical problem is related to the differential diagnosis of these conditions. The purpose of this prospective clinical study is to compare the efficacy of two techniques of PET/CT imaging in the differential diagnosis of these complications. Positron Emission Tomography (PET)/Computed Tomography (CT) imaging, performed during a single day, will include the head-to-head comparison of 18F-Fluoro-D-Glucose (18F-FDG) PET/CT and 68Gallium-citrate (68Ga-citrate) PET/CT imaging.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2012

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

September 19, 2013

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 28, 2013

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2016

Completed
Last Updated

August 3, 2017

Status Verified

August 1, 2017

Enrollment Period

4.3 years

First QC Date

September 19, 2013

Last Update Submit

August 2, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Exclusion of the presence of periprosthetic joint infection in ARMD patients

    The two PET imaging techniques are expected to rule out infection in patients with ARMD due to metal-on-metal bearings

    Clinical follow-up of 3 years or more after PET/CT imaging

Study Arms (3)

Adverse reaction to metal debris

ACTIVE COMPARATOR

68Ga-citrate and 19F-FDG PET/CT imaging of hip replacement patients with adverse tissue reactions to metal debris

Diagnostic Test: 68Ga-citrate and 18F-FDG PET/CT imaging

Periprosthetic joint infection

ACTIVE COMPARATOR

68Ga-citrate and 19F-FDG PET/CT imaging of hip replacement patients with periprosthetic joint infection

Diagnostic Test: 68Ga-citrate and 18F-FDG PET/CT imaging

Aseptic mechanical implant loosening

ACTIVE COMPARATOR

68Ga-citrate and 19F-FDG PET/CT imaging of patients with aseptic mechanical loosening of hip prosthesis

Diagnostic Test: 68Ga-citrate and 18F-FDG PET/CT imaging

Interventions

Single-day study of the two PET tracers

Adverse reaction to metal debrisAseptic mechanical implant looseningPeriprosthetic joint infection

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients with uncemented total hip replacement
  • American Society of Anesthesiology score I-III
  • Group 1: local symptoms and MRI findings of the operated hip fulfilling the criteria of ARMD due to metal-on-metal bearings of the hip prosthesis, infection ruled out
  • Group 2: bacteriologically verified periprosthetic infection of the hip prosthesis
  • Group 3: local symptoms and radiographic findings of the hip prosthesis fulfilling the criteria of aseptic mechanical implant loosening, infection ruled out

You may not qualify if:

  • any related condition of the index hip which requires immediate surgical intervention, such as a septic infection or a periprosthetic fracture
  • any systemic disorder or condition (ASA IV) which makes the patient an unlikely candidate for revision surgery of the affected hip implant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Turku University Hospital

Turku, 20521, Finland

Location

Related Publications (5)

  • Lankinen P, Lehtimaki K, Hakanen AJ, Roivainen A, Aro HT. A comparative 18F-FDG PET/CT imaging of experimental Staphylococcus aureus osteomyelitis and Staphylococcus epidermidis foreign-body-associated infection in the rabbit tibia. EJNMMI Res. 2012 Jul 23;2(1):41. doi: 10.1186/2191-219X-2-41.

    PMID: 22824200BACKGROUND
  • Lankinen P, Makinen TJ, Poyhonen TA, Virsu P, Salomaki S, Hakanen AJ, Jalkanen S, Aro HT, Roivainen A. (68)Ga-DOTAVAP-P1 PET imaging capable of demonstrating the phase of inflammation in healing bones and the progress of infection in osteomyelitic bones. Eur J Nucl Med Mol Imaging. 2008 Feb;35(2):352-64. doi: 10.1007/s00259-007-0637-5. Epub 2007 Nov 24.

    PMID: 18038133BACKGROUND
  • Makinen TJ, Lankinen P, Poyhonen T, Jalava J, Aro HT, Roivainen A. Comparison of 18F-FDG and 68Ga PET imaging in the assessment of experimental osteomyelitis due to Staphylococcus aureus. Eur J Nucl Med Mol Imaging. 2005 Nov;32(11):1259-68. doi: 10.1007/s00259-005-1841-9. Epub 2005 Jul 9.

    PMID: 16007423BACKGROUND
  • Koort JK, Makinen TJ, Knuuti J, Jalava J, Aro HT. Comparative 18F-FDG PET of experimental Staphylococcus aureus osteomyelitis and normal bone healing. J Nucl Med. 2004 Aug;45(8):1406-11.

    PMID: 15299068BACKGROUND
  • Ahtinen H, Kulkova J, Lindholm L, Eerola E, Hakanen AJ, Moritz N, Soderstrom M, Saanijoki T, Jalkanen S, Roivainen A, Aro HT. (68)Ga-DOTA-Siglec-9 PET/CT imaging of peri-implant tissue responses and staphylococcal infections. EJNMMI Res. 2014 Aug 8;4:45. doi: 10.1186/s13550-014-0045-3. eCollection 2014.

    PMID: 25520903BACKGROUND

Study Officials

  • Hannu T Aro, MD, PhD

    Turku University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Intra-individual comparison of two diagnostic PET imaging tracers
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 19, 2013

First Posted

October 28, 2013

Study Start

October 1, 2012

Primary Completion

December 31, 2016

Study Completion

December 31, 2016

Last Updated

August 3, 2017

Record last verified: 2017-08

Locations